Day: October 17, 2025

The Board of AB Nasdaq Vilnius adopted the decision to delist the shares of PST Group AB from trading on regulated market

Written by Customer Service on October 17, 2025. Posted in Public Companies.

PST Group AB (the “Company”) hereby informs that the Board of AB Nasdaq Vilnius (“Nasdaq”) adopted a decision to delist the shares of the Company, ISIN LT0000101446, from trading on the regulated market Nasdaq, establishing that the date of coming into force of this decision is 31 December 2025 – i. e., the last trading day of shares of the Company on the regulated market Nasdaq is 31 December 2025.This decision is adopted considering the decision of the Extraordinary General Meeting of Shareholders of the Company which took place on 30 June 2025 to initiate delisting of all the outstanding shares of the Company and delist them from trading on the regulated market Nasdaq. More information:Tomas StukasManaging DirectorTel.: +370 618 21360

24/7 Market News- Kraig Labs Spider Silk Poised to Lead the Sustainable Textile Revolution

Written by Customer Service on October 17, 2025. Posted in Public Companies.

Circular Fashion Gains Momentum DENVER, Oct. 17, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that, as the fashion industry confronts mounting pressure to overhaul its wasteful practices, Circular Fashion is emerging as both an ethical mandate and a massive economic opportunity. Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, is positioning to be at the forefront of this transformation, offering a scalable, biodegradable alternative to petroleum-based fabrics that could reshape the $1.5 trillion global apparel industry. The Circular Economy’s Billion-Dollar Fashion Upside Circular fashion, a model that emphasizes durability, recyclability,...

Private Bancorp of America, Inc. Announces Continued Strong Net Income and Core Deposit Growth for Third Quarter 2025

Written by Customer Service on October 17, 2025. Posted in Earnings Releases And Operating Results.

Third Quarter 2025 HighlightsNet income for the third quarter of 2025 was $9.7 million, compared to $10.4 million in the prior quarter and $9.5 million in the third quarter of 2024. Net income increased 2.6% year over year. Results for the third quarter of 2025 reflect the reversal of $1.3 million of interest income and a $1.0 million increase in reserves for loans placed on nonaccrual during the quarter. Net income for the third quarter of 2025 represents a return on average assets of 1.51% and a return on average tangible common equity of 15.28% Diluted earnings per share for the third quarter of 2025 was $1.65, compared to $1.77 in the prior quarter and $1.63 in the third quarter of 2024 Core deposits were $2.19 billion as of September 30, 2025, an increase of $121.1 million or 5.8% from June 30, 2025. Year over year, core deposits...

Evaxion reports 75% Objective Response Rate in phase 2 trial with AI-designed personalized cancer vaccine EVX-01

Written by Customer Service on October 17, 2025. Posted in Public Companies.

75% Objective Response Rate as 12 out of 16 advanced melanoma patients had objective clinical responses, with 11 of the 12 responders continuing to respond at 24 months follow-up Immune activation observed in all patients with 81% of EVX-01’s vaccine targets triggering a specific response Treatment was well tolerated Data is presented today at the ESMO Congress and will be discussed at a webinar with key opinion leader Professor Muhammad Adnan Khattak on October 22, 2025COPENHAGEN, Denmark, October 17, 2025 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces new two-year unprecedented clinical efficacy data of its personalized cancer vaccine EVX-01 in patients with advanced melanoma. The two-year phase 2 data demonstrates an Objective...

Royalty Pharma Declares Fourth Quarter 2025 Dividend

Written by Customer Service on October 17, 2025. Posted in Dividend Reports And Estimates.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on December 10, 2025, to shareholders of record at the close of business on November 14, 2025. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s...

Interfor Announces Incremental Lumber Production Curtailments for the Fourth Quarter of 2025

Written by Customer Service on October 17, 2025. Posted in Public Companies.

BURNABY, B.C., Oct. 17, 2025 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) announced today revised operating plans for the fourth quarter of 2025. Due to persistently weak market conditions and ongoing economic uncertainty, Interfor will further temporarily reduce lumber production across its operations in British Columbia, Ontario, the US Pacific Northwest and the US South. These curtailments are expected to reduce lumber production in the fourth quarter of 2025 by approximately 250 million board feet, or 26%, as compared to the second quarter of 2025, which reflected a more normal operating stance. The curtailment volumes are approximately evenly split between Interfor’s Canadian and U.S. operations. Interfor produced 936 million board feet of lumber in the second quarter of 2025 and approximately...

UCLOUDLINK GROUP INC. Announces Plan to Establish New Operational Structure for Its Pet-Tech Business

Written by Customer Service on October 17, 2025. Posted in Public Companies.

HONG KONG, Oct. 17, 2025 (GLOBE NEWSWIRE) — UCLOUDLINK GROUP INC. (NASDAQ: UCL) (“UCLOUDLINK” or the “Company”), the world’s first and leading mobile data traffic sharing marketplace, today announced that its board of directors has approved a plan to operate its pet-tech business under a new operational structure. The initiative will incorporate a new Cayman Islands-based holding company (the “New Company”) within UCLOUDLINK, which will be supported by local operating subsidiaries of the New Company, to create a global foundation for the pet-tech business. The New Company and its subsidiaries will focus on building an AI-powered smart wearable ecosystem for pets and develop an online interactive platform that connects among pets, pets’ owners, pets’ fans and communities in real time across the globe. This platform will integrate...

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

Written by Customer Service on October 17, 2025. Posted in Mergers And Acquisitions.

Acquisition includes novel new chemical entity VB4-P5 with potential to address significant unmet needs in rare and large-market kidney diseases CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that it has entered into a binding term sheet (the “Term Sheet”) to acquire a Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems Limited, an Australian Securities Exchange listed company (“Vectus”). The program includes a novel new chemical entity, VB4-P5, along with its associated intellectual property, regulatory documentation, and manufacturing data. The program is currently at the pre-IND...

Guardian Capital Announces October 2025 Cash Distributions for Guardian Capital ETFs

Written by Customer Service on October 17, 2025. Posted in Dividend Reports And Estimates.

TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) — Guardian Capital LP (the “Manager”) announces the following regular cash distributions for the period ending October 31, 2025, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on October 31, 2025 to unitholders of record on October 27, 2025. The ex-dividend date in each case is anticipated to be October 27, 2025.Guardian Capital ETFs Series of ETF Units DistributionFrequency TradingSymbol Exchange Distribution Amount(per ETF Unit)GuardBondsTM2025 Investment Grade Bond Fund ETF Units Monthly GBFB Cboe Canada CAD$0.0370GuardBondsTM2026 Investment Grade Bond Fund ETF Units Monthly GBFC Cboe Canada CAD$0.0259GuardBondsTM2027 Investment Grade Bond Fund ETF Units Monthly GBFD Cboe Canada CAD$0.0287GuardBondsTM2028...

Genco Shipping & Trading Limited Announces Third Quarter 2025 Conference Call and Webcast

Written by Customer Service on October 17, 2025. Posted in Public Companies.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE: GNK) announced today that it will hold a conference call to discuss the Company’s results for the third quarter of 2025 on Thursday, November 6, 2025 at 8:30 a.m. Eastern Time. The conference call will also be broadcast live over the Internet and include a slide presentation. The Company will issue financial results for the third quarter ended September 30, 2025 on Wednesday, November 5, 2025 after the close of market trading. What: Third Quarter 2025 Conference Call When: Thursday, November 6, 2025 at 8:30 a.m. Eastern Time Link: https://registrations.events/direct/Q4I910613917 To access the call by phone, please register via the live call registration link above and you will be provided with dial-in instructions and details. Please dial in...

Day: October 17, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals